FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-8211com.
(The FASEB Journal. 2007;21:3369-3379.)
© 2007 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.07-8211comv1
21/12/3369    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Tuyn, J.
Right arrow Articles by Atsma, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Tuyn, J.
Right arrow Articles by Atsma, D. E.

Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene

John van Tuyn*,{dagger},{ddagger},1, Daniël A. Pijnappels*,1, Antoine A. F. de Vries{dagger}, Ingrid de Vries{dagger}, Ietje van der Velde-van Dijke{dagger}, Shoshan Knaän-Shanzer{dagger}, Arnoud van der Laarse*, Martin J. Schalij* and Douwe E. Atsma*,2

* Department of Cardiology,

{dagger} Virus and Stem Cell Biology Laboratory, Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands; and

{ddagger} Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands

2Correspondence: Department of Cardiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail: d.e.atsma{at}lumc.nl

Myocardial scar formation impairs heart function by inducing cardiac remodeling, decreasing myocardial compliance, and compromising normal electrical conduction. Conversion of myocardial scar fibroblasts (MSFs) into (functional) cardiomyocytes may be an effective alternative treatment to limit loss of cardiac performance after myocardial injury. In this study, we investigated whether the phenotype of MSFs can be modified by gene transfer into cells with properties of cardiomyocytes. To this end, fibroblasts from postmyocardial infarction scars of human left ventricles were isolated and characterized by cell biological, immunological, and molecular biological assays. Cultured human MSFs express GATA4 and connexin 43 and display adipogenic differentiation potential. Infection of human MSFs with a lentivirus vector encoding the potent cardiogenic transcription factor myocardin renders them positive for a wide variety of cardiomyocyte-specific proteins, including sarcomeric components, transcription factors, and ion channels, and induces the expression of several smooth muscle marker genes. Forced myocardin expression also endowed human MSFs with the ability to transmit an action potential and to repair an artificially created conduction block in cardiomyocyte cultures. These finding indicate that in vivo myocardin gene transfer may potentially limit cardiomyocyte loss, myocardial fibrosis, and disturbances in electrical conduction caused by myocardial infarction.—van Tuyn, J., Pijnappels, D. A., de Vries, A. A. F., de Vries, I., van der Velde-van Dijke, I., Knaän-Shanzer, S., van der Laarse, A., Schalij, M. J., Atsma, D. E. Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene.


Key Words: conduction (block) • fibrosis • gene transfer • heart infarction • myocytes




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Long, R. D. Bell, W. T. Gerthoffer, B. V. Zlokovic, and J. M. Miano
Myocardin Is Sufficient for a Smooth Muscle-Like Contractile Phenotype
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1505 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. W. Grauss, J. van Tuyn, P. Steendijk, E. M. Winter, D. A. Pijnappels, B. Hogers, A. C. Gittenberger-De Groot, R. van der Geest, A. van der Laarse, A. A.F. de Vries, et al.
Forced Myocardin Expression Enhances the Therapeutic Effect of Human Mesenchymal Stem Cells After Transplantation in Ischemic Mouse Hearts
Stem Cells, April 1, 2008; 26(4): 1083 - 1093.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The Federation of American Societies for Experimental Biology.